Category: Molecular Diagnostics
Molecular Diagnostics market research reports by Frost & Sullivan
-
Molecular Diagnostics for Neurodegenerative Diseases: Technology Growth Opportunities, 2024–2028
Molecular Diagnostics for Neurodegenerative Diseases: Technology Growth Opportunities, 2024–2028 Leveraging integrated and point-of-care diagnostics with multiomics represents the most promising growth opportunity to advance molecular diagnostics for neurodegenerative diseases Neurodegenerative dise ... Read More
-
Global Molecular Diagnostics Market, Forecast to 2029
Global Molecular Diagnostics Market, Forecast to 2029 Molecular Diagnostics Unleash Growth Opportunities, Steering Innovation Personalized Medicine The global molecular diagnostic market will experience significant growth due to a broad range of factors, such as increased demand from the COVID-19 pa ... Read More
-
Global Clinical Diagnostics Outlook, 2024
Global Clinical Diagnostics Outlook, 2024 Driven by Digital Services and Automation, the Molecular Diagnostics and POCT Sectors Rebound after the COVID-19 Pandemic With the end of the COVID-19 pandemic, healthcare providers have been directing most of their capabilities toward preventive healthcare ... Read More
-
Frost Radar™: Predictive Genetic Testing Technologies, 2023
Frost Radar™: Predictive Genetic Testing Technologies, 2023 A Benchmarking System to Spark Companies to Action - Innovation That Fuels New Deal Flow and Growth Pipelines Predictive genetic testing (PGT) comprises analysis of genes, the whole genome, or exomes to predict the risk of a wide range of d ... Read More
-
Asia-Pacific Next-generation Diagnostics Outlook, 2023
Asia-Pacific Next-generation Diagnostics Outlook, 2023 The Renewed Focus on Infectious Diseases Outside COVID-9, Oncology, Cardiovascular, Diabetes, and Prenatal Care will Drive Market Growth The Asia-Pacific next-generation diagnostics market's revenue is projected to decline by 5.0% in 2023, attri ... Read More
-
Global Prenatal Genetic Testing—Forecast to 2026
Global Prenatal Genetic Testing—Forecast to 2026 New technological advances in prenatal genetic testing include the enhancement of the next-generation sequencing (NGS) technology, chromosomal microarray analysis (CMA) tool, and PCR TaqMan. These improve precision and specificity in genome profiling, ... Read More
-
United States Molecular Point-of-Care Testing Growth Opportunities
United States Molecular Point-of-Care Testing Growth Opportunities Rapid advancements in infectious disease diagnostics continue with novel identification methods and healthcare accessibility improvements. The shift from traditional testing to a more technologically empowered, consumer-centric testi ... Read More
-
Next-generation Diagnostics Outlook, 2022
Next-generation Diagnostics Outlook, 2022 In vitro diagnostics introduces new technologies, sequencing methods, novel software algorithms, and multi-omics approaches to realise the goal of personalized medicine. Next-generation diagnostics has been the backbone of COVID-19-related emergency diagnosi ... Read More
-
AI Augmentation in Molecular Diagnostics
AI Augmentation in Molecular Diagnostics This Frost & Sullivan research service discusses advances in AI integration in Molecular Diagnostics, highlights key advantages of incorporating AI in the diagnostics workflow and roadblocks that have prevented it from becoming mainstream. While AI is widely ... Read More
Research Assistance
